By the end of the experimental protocol, interesting and significant trends among levels of anti-oxidant markers (SOD, CAT, GSH, GPx) activities in multiple sclerosis and the treatment groups were observed (Table 3). This evidence concerns the gene SOD1 and multiple sclerosis.